For example, the bromodomain inhibitor JQ1 significantly reduced PD-L1 expression on TAMs and dendritic cells, induced increased T cell cytotoxic activity and suppressed OC tumor growth in preclinical models [171]. Here, CD274 is linked to neoplasm.